Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy.

Belančić A, Skroče K, Gkrinia EMM, Marinović Glavić M, Kwok MK.

Open source

DOI
10.3390/jcm15155870
Published
2026-07-27
Container
J Clin Med
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15155870,
  title = {Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy.},
  author = {Belančić A and  Skroče K and  Gkrinia EMM and  Marinović Glavić M and  Kwok MK.},
  year = {2026},
  journal = {J Clin Med},
  doi = {10.3390/jcm15155870},
  url = {https://doi.org/10.3390/jcm15155870}
}

RIS

TY  - JOUR
TI  - Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy.
AU  - Belančić A
AU  -  Skroče K
AU  -  Gkrinia EMM
AU  -  Marinović Glavić M
AU  -  Kwok MK.
PY  - 2026
JO  - J Clin Med
DO  - 10.3390/jcm15155870
UR  - https://doi.org/10.3390/jcm15155870
ER  - 

APA

A, B., K, S., EMM, G., M, M. G., & MK., K. (2026). Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy.. J Clin Med. https://doi.org/10.3390/jcm15155870

Source records